Celiac and Superior/Inferior Mesenteric Angioplasty and Stenting for Chronic Mesenteric Ischemia: A Single-Center Experience. (August 2017)

• Record Type: Journal Article
• Authors: Rajaratnam, Kanapathi; Paraskevas, Kosmas I.; Ramli, Ahmad Hariz; Shehata, Amro; Jackson, Ralph; Clarke, Michael J.
• Is Part Of: Angiology. Volume 68:Number 7(2017)
• Page Start: 571
• Page End: 574
• Publication Date: 2017-08
• Subjects: angioplasty -- stenting -- chronic mesenteric ischemia -- revascularization; Blood-vessels -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.13005
• DOI: 10.1177/0003319716662424
• Languages: English
• ISSNs: 0003-3197

Abstract

Angioplasty and stenting emerged as the less invasive treatment options compared to open surgical revascularization for the management of patients with chronic mesenteric ischemia (CMI). However, endovascular techniques may not achieve symptomatic relief in many patients with CMI. We report our results from the endovascular management of patients with CMI. Data were reviewed from 45 patients undergoing celiac and/or mesenteric angioplasty and stenting for CMI, from October 2006 to January 2016. Angioplasty and stenting of celiac and/or mesenteric arteries were successful in relieving symptoms completely in 29 of 45 and partially in 6 of 45 patients. Only 10 of 45 patients mentioned no improvement, while symptom recurrence occurred in another 3 of 45 patients between 3 and 36 months postprocedurally due to stent occlusion. Angioplasty and stenting of celiac and/or mesenteric arteries provide symptomatic relief in a considerable percentage of patients with CMI. If symptoms fail to improve, an open surgical revascularization procedure should be considered.